Trial intelligence / Profile preview

Propofol pharmacokinetics in children with obesity

ACTRN12611000451909Phase 4Not yet recruiting

Sponsor
Auckland City Hospital
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol in childhood obesity (2 arms), sponsored by Auckland City Hospital. Primary endpoint: Arterial blood concentration of propofol versus time. Planned start Nov 2011; status: not yet recruiting.

02

Drugs

propofol
03

Conditions

childhood obesity

Beyond the preview

Go deeper on ACTRN12611000451909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000451909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call